Hoenigl, Martin
Chaillon, Antoine
Moore, David J.
Morris, Sheldon R.
Mehta, Sanjay R.
Gianella, Sara
Amico, K. Rivet
Little, Susan J.
Article History
Received: 17 June 2016
Accepted: 18 August 2016
First Online: 6 September 2016
Competing interests
: Dr. Hoenigl served on the speakers’ bureau of Merck. Dr. Moore, Dr. Morris and Dr. Little reported grant funding from Gilead Sciences, Inc. All other authors no conflicts.